Moderna Cuts 2026 Cash Cost Outlook to $4B, Reaffirms Revenue Growth
Moderna forecasts up to 10% revenue growth for 2026 while reducing cash cost guidance to approximately $4 billion. Moderna revised its 2026 cash cost guidance downward to around $4 billion while maintaining its revenue growth forecast of up to 10%. The company reported Q2